These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 9472698)
41. Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis. Hisamuddin IM; Wehbi MA; Chao A; Wyre HW; Hylind LM; Giardiello FM; Yang VW Clin Cancer Res; 2004 Dec; 10(24):8357-62. PubMed ID: 15623613 [TBL] [Abstract][Full Text] [Related]
42. Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac. Keller JJ; Offerhaus GJ; Polak M; Goodman SN; Zahurak ML; Hylind LM; Hamilton SR; Giardiello FM Gut; 1999 Dec; 45(6):822-8. PubMed ID: 10562579 [TBL] [Abstract][Full Text] [Related]
43. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice. Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589 [TBL] [Abstract][Full Text] [Related]
44. [Role of suindac in the treatment of familial adenomatous polyposis coli]. Landauer S; Halimi C; Caulin C; Bergmann JF Therapie; 1999; 54(6):675-82. PubMed ID: 10709439 [TBL] [Abstract][Full Text] [Related]
45. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825 [TBL] [Abstract][Full Text] [Related]
46. APC in the regulation of intestinal crypt fission. Wasan HS; Park HS; Liu KC; Mandir NK; Winnett A; Sasieni P; Bodmer WF; Goodlad RA; Wright NA J Pathol; 1998 Jul; 185(3):246-55. PubMed ID: 9771477 [TBL] [Abstract][Full Text] [Related]
47. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis. Watson SA; Smith AM Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260 [TBL] [Abstract][Full Text] [Related]
48. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? Alberts DS; Hixson L; Ahnen D; Bogert C; Einspahr J; Paranka N; Brendel K; Gross PH; Pamukcu R; Burt RW J Cell Biochem Suppl; 1995; 22():18-23. PubMed ID: 8538196 [TBL] [Abstract][Full Text] [Related]
49. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice. Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216 [TBL] [Abstract][Full Text] [Related]
50. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice. Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636 [TBL] [Abstract][Full Text] [Related]
51. Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model. Girardi B; Pricci M; Giorgio F; Piazzolla M; Iannone A; Losurdo G; Principi M; Barone M; Ierardi E; Di Leo A World J Gastroenterol; 2020 Apr; 26(14):1601-1612. PubMed ID: 32327909 [TBL] [Abstract][Full Text] [Related]
52. Novel cell culture model for prevention of carcinogenic risk in familial adenomatous polyposis syndrome. Telang N; Katdare M Oncol Rep; 2009 Apr; 21(4):1017-21. PubMed ID: 19288003 [TBL] [Abstract][Full Text] [Related]
53. Defective acute apoptotic response to genotoxic carcinogen in small intestine of APC(Min/+) mice is restored by sulindac. Hu Y; Le Leu RK; Young GP Cancer Lett; 2007 Apr; 248(2):234-44. PubMed ID: 16950562 [TBL] [Abstract][Full Text] [Related]
55. Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis. Hisamuddin IM; Wehbi MA; Schmotzer B; Easley KA; Hylind LM; Giardiello FM; Yang VW Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2366-9. PubMed ID: 16214918 [TBL] [Abstract][Full Text] [Related]
56. Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention. Winde G; Lügering N; Glodny B; Schmid KW; Müller O; Senninger N; Osswald H Cancer Lett; 1998 Dec; 134(2):201-7. PubMed ID: 10025882 [TBL] [Abstract][Full Text] [Related]
57. Combined Treatment with a WNT Inhibitor and the NSAID Sulindac Reduces Colon Adenoma Burden in Mice with Truncated APC. Faux MC; Weinstock J; Gogos S; Prato E; Azimpour AI; O'Keefe R; Cathcart-King Y; Garnham AL; Ernst M; Preaudet A; Christie M; Putoczki TL; Buchert M; Burgess AW Cancer Res Commun; 2022 Feb; 2(2):66-77. PubMed ID: 36860494 [TBL] [Abstract][Full Text] [Related]
58. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Piazza GA; Alberts DS; Hixson LJ; Paranka NS; Li H; Finn T; Bogert C; Guillen JM; Brendel K; Gross PH; Sperl G; Ritchie J; Burt RW; Ellsworth L; Ahnen DJ; Pamukcu R Cancer Res; 1997 Jul; 57(14):2909-15. PubMed ID: 9230200 [TBL] [Abstract][Full Text] [Related]
59. Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the Apc(Min/+) mouse model. Li S; Ghaleb AM; He J; Bughani U; Bialkowska AB; Yang VW; Joshi HC Int J Cancer; 2012 Sep; 131(6):1435-44. PubMed ID: 22052467 [TBL] [Abstract][Full Text] [Related]
60. Inhibition of angiogenesis by sulindac and its sulfone metabolite (FGN-1): a potential mechanism for their antineoplastic properties. Skopińska-Rózewska E; Piazza GA; Sommer E; Pamukcu R; Barcz E; Filewska M; Kupis W; Caban R; Rudziński P; Bogdan J; Mlekodaj S; Sikorska E Int J Tissue React; 1998; 20(3):85-9. PubMed ID: 9894180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]